Mammotome微创旋切系统结合超声BI-RADS评级在乳腺癌早期诊断中的应用  

Ultrasound-guided Mammotome invasive biopsy system and BI-RADS-US in the early diagnosis of breast cancer

作　　者：肖光雄[1] 贾敏[1] 许军[1] 金哲龙[1] 

机构地区：[1]湖北省荆门市第一人民医院乳腺科,湖北荆门448000

出　　处：《癌变．畸变．突变》2010年第6期462-464,共3页Carcinogenesis,Teratogenesis & Mutagenesis

摘　　要：目的:探讨Mammotome微创旋切系统(简称Mammotome系统)结合超声BI-RADS评级在乳腺癌早期诊断中的应用,并对比分析采用Mammotome系统与传统开放手术对良性乳腺微小肿瘤的临床治疗效果。方法:采用我院2008年3月至2009年3月Mammotome系统及影像定位后,传统手术切除的97例乳腺微小肿瘤(<1 cm)患者的临床资料进行回顾性统计分析。结果:根据全部病例病检结果,超声BI-RADS评级预测乳腺微小肿瘤良恶性质的灵敏度为82.35%(14/17),特异度为97.5%(78/80),阳性预测率为87.5%(14/16),阴性预测率为96.30%(78/81),符合率94.84%[(78+14)/97]。97例中经术后病理诊断为良性者80例,采用Mammotome手术组60例,采用开放手术组20例,经术后彩超复查均无漏切、无肿瘤影像残余;与传统开放手术切除组比较,Mammotome系统手术组术中出血量少、切口愈合时间短、术后瘢痕小,其差异均具有统计学意义(P<0.05)。结论:超声BI-RADS评级能较准确反应乳腺肿块的良恶性质,结合Mammotome系统能在乳腺癌的早期诊断中取得良好效果,采用Mammotome系统治疗乳腺良性微小肿瘤较传统开放手术的临床效果更佳。OBJECTIVE： To investigate the use of Mammotome minimally invasive biopsy system and BI-RADS-US in the early diagnosis of breast carcer.METHODS： Clinical record of 97 tiny breast tumor（1 cm） in our hospital from March 2008 to March 2009 were reviewed and analyzed.RESULTS： Using BI-RADS-US to predict histopathologic diagnosis of tiny breast tumor,sensitivity was 82.35%,specificity 97.5%,positive predictive value 87.5%,negative predictive value 96.30%,compliance rate 94.84%.The differences in bleeding,wound healing and scar size between mini-cut Mammotome group and open operation group in benign tiny breast tumor revealed statistical significance（P0.05）.CONCLUSION： BI-RADS-US could provide accurate histopathologic diagnosis of tiny breast tumor.Moreover,combining this with Mammotome minimally invasive biopsy system could cure tiny breast tumors.

关 键 词：MAMMOTOME微创旋切系统 超声BI-RADS 乳腺癌 

分 类 号：R737.9[医药卫生—肿瘤]